Skip to content

Atrial Fibrillation and Carotid Atherosclerosis in Ischemic Stroke Patients-(AFCAS)

Carotid Artery Atherosclerosis in Ischemic Stroke Patients With Atrial Fibrillation.(Atrial Fibrillation and Carotid Atherosclerosis in Ischemic Stroke Patients- AFCAS)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04821700
Acronym
AFCAS
Enrollment
3000
Registered
2021-03-29
Start date
2020-03-20
Completion date
2021-04-05
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Carotid Stenosis, Ischemic Stroke

Keywords

Ischemic Stroke, Atrial fibrillation, carotid stenosis, atherosclerosis

Brief summary

The main aim of the study is to investigate the prevalence and characteristics of ischemic stroke patients with atrial fibrillation and concurrent carotid atherosclerosis. Additionally, this study will investigate the effect of concurrent carotid atherosclerosis on the outcomes of recurrent stroke, myocardial infarction and death during follow-up

Interventions

BIOLOGICALCarotid Stenosis

To investigate if the concurrent presence of carotid stenosis has any effect on future outcomes of patients with ischemic stroke and atrial fibrillation

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Hospitalization due to ischemic stroke * Atrial fibrillation * Αny type of carotid vascular imaging

Exclusion criteria

* Intracerebral haemorrhage on admission * Haemorrhagic transformation on admission

Design outcomes

Primary

MeasureTime frame
Death during follow-upFrom date of randomization until the date of death from any cause, assessed up to 60 months
Stroke recurrenceFrom date of randomization until the date of stroke recurrence, assessed up to 60 months
Myocardial infarctionFrom date of randomization until the date of myocardial infarction, assessed up to 60 months

Secondary

MeasureTime frameDescription
modified Rankin Scale at 3 months3 monthsmRS: modified Rankin Scale; 0=No symptoms at all; 1=No significant disability despite symptoms: able to carry out all usual duties and activities; 2=Slight disability: unable to carry out all previous activities, but able to look after own affairs without assistance; 3= Moderate disability: requiring some help, but able to walk without assistance; 4=Moderately severe disability: unable to walk without assistance and unable to attend to own bodily needs without assistance; 5=Severe disability: bedridden, incontinent and requiring constant nursing care and attention; 6=Dead

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026